Literature DB >> 3290027

[Arrhythmogenic right ventricular dysplasia. Study of a selected population].

A Nava1, B Martini, G Thiene, G F Buja, B Canciani, R Scognamiglio, G Miraglia, D Corrado, G M Boffa, L Daliento.   

Abstract

268 patients (pts) aged between 4 and 63 (average block 33.6) years were examined in an effort to detect structural and/or wall motion abnormalities of the right ventricle, consistent with a diagnosis of Arrhythmogenic Right Ventricular Dysplasia (ARVD). The patients included in this study had some of these features: 1) sudden juvenile death (age less than 35 years) due to heart disease; 2) relatives of pts died suddenly of pathologically proven ARVD; 3) pts with ventricular arrhythmias grade Lown greater than 3, and with QRS morphology mainly of left bundle branch block; 4) pts between the ages of 18 and 40, with negative T waves beyond V2; 5) pts with ventricular arrhythmias of left bundle branch block morphology, and grade Lown greater than 1, and negative T waves beyond V1. ARVD was recognized in 108 living and 18 deceased pts. Our data confirm that ARVD is a wide spectrum disease, going from the classical form described by Marcus and Fontaine to concealed forms characterized mainly by premature ventricular complexes.

Entities:  

Mesh:

Year:  1988        PMID: 3290027

Source DB:  PubMed          Journal:  G Ital Cardiol        ISSN: 0046-5968


  3 in total

1.  Right ventricular dysplasia: a clinical and pathological study of two families with left ventricular involvement.

Authors:  D Miani; B Pinamonti; R Bussani; F Silvestri; G Sinagra; F Camerini
Journal:  Br Heart J       Date:  1993-02

Review 2.  Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems.

Authors:  Mitja Lainscak; Stefan D Anker
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 3.  "Ryanopathies" and RyR2 dysfunctions: can we further decipher them using in vitro human disease models?

Authors:  Yvonne Sleiman; Alain Lacampagne; Albano C Meli
Journal:  Cell Death Dis       Date:  2021-11-01       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.